We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Brain Stem Cells Produce Insulin

By Biotechdaily staff writers
Posted on 13 May 2005
Researchers have been able to coax stem cells from the brain to mature into cells that can produce insulin and release it when sugar is added to the environment. More...
This feat could lead to new ways of transplanting insulin-producing cells into diabetics.

Because embryonic stem cells are difficult to work with in a laboratory and most existing human embryonic stem cells lines are contaminated and cannot be transplanted into humans, an alternative was sought by Seung Kim, M.D., Ph.D., assisstant professor of developmental biology at the Stanford University School of Medicine (Palo Alto, CA).

Dr. Kim thought that human neural stem cells might work. "When you look at islet cells you realize that they resemble neurons,” he noted. Like neurons, islet cells respond to external signals by changing their electrical properties and releasing packages of proteins. In the case of islets, that protein is insulin. In fact, the cells that produce insulin and regulate sugar in fruit flies are neurons.

Working with the cells in a lab dish, Dr. Kim and postdoctoral fellow Yuichi Hori, M.D., Ph.D., added a cocktail of chemicals in a sequence they knew might prod the stem cells to mature into insulin-producing cells. The result was a dish full of cells that could produce insulin and release it in response to sugar being added. These cells did not perfectly mimic human islet cells. They made some, but not all, proteins normally made by islet cells and they continued to make some proteins found in neurons.

Dr. Kim then transplanted the cells into a cavity in the kidneys of mice. When the blood sugar went up in these mice, the cells released insulin. After four weeks, the cells were still alive and producing insulin. Although the amount of insulin produced was not enough to treat diabetes, the work is a first step toward that eventual goal. Dr. Kim is the lead author of a paper describing the project, published in the April 26, 2005, issue of PLoS Medicine.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.